Deerfield Management Company, L.P. 13F holdings, Q2 2026
Holdings as of June 30, 2026 · filings on SEC EDGAR · this is the latest filing on record
Deerfield Management Company, L.P. disclosed 82 US equity positions worth $9.6bn in its Q2 2026 13F filing. The largest position was NUVALENT INC at 22.2% of the reported book, followed by BROOKDALE SR LIVING INC and RVMD. Against the Q1 2026 filing, it opened 5 new positions, added to 12 and reduced 9 among the top 50 holdings.
What did Deerfield Management Company, L.P. own in Q2 2026? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2026 |
|---|---|---|---|---|---|---|---|
| 1 | NUVALENT INC | 22.2% | $2.1bn | 17,248,450 | 0% | held | |
| 2 | BROOKDALE SR LIVING INC | 6.1% | $585.7m | 306,885,000 | 0% | held | |
| 3 | RVMD REVOLUTION MEDICINES INC | Healthcare | 4.7% | $448.0m | 2,392,000 | 4% | added |
| 4 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 3.4% | $322.5m | 963,351 | 0% | held |
| 5 | VTRS VIATRIS INC | Healthcare | 3.3% | $320.9m | 20,206,170 | 0% | held |
| 6 | CNC CENTENE CORP DEL | Healthcare | 3.3% | $314.6m | 4,901,000 | -17% | reduced |
| 7 | REVOLUTION MEDICINES INC | 2.6% | $251.7m | 200,000,000 | – | new | |
| 8 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 2.6% | $247.6m | 457,000 | 0% | held |
| 9 | ARROWHEAD PHARMACEUTICALS IN | 2.5% | $240.5m | 200,000,000 | 0% | held | |
| 10 | LEGN LEGEND BIOTECH CORP | Healthcare | 2.5% | $235.0m | 8,137,638 | 6% | added |
| 11 | COGT COGENT BIOSCIENCES INC | Healthcare | 2.0% | $193.7m | 5,006,104 | -45% | reduced |
| 12 | GMAB GENMAB A/S | Healthcare | 2.0% | $188.6m | 6,865,000 | 179% | added |
| 13 | BKD BROOKDALE SR LIVING INC | Healthcare | 2.0% | $187.2m | 11,637,032 | 0% | held |
| 14 | VERA VERA THERAPEUTICS INC | Healthcare | 1.8% | $168.1m | 3,916,400 | 5% | added |
| 15 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 1.6% | $157.0m | 1,979,669 | 0% | held |
| 16 | CELC CELCUITY INC | Healthcare | 1.6% | $151.8m | 1,451,014 | -15% | reduced |
| 17 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 1.6% | $151.0m | 15,096,403 | 0% | held |
| 18 | NEWAMSTERDAM PHARMA COMPANY | 1.5% | $144.5m | 4,264,789 | 0% | held | |
| 19 | ACHC ACADIA HEALTHCARE COMPANY IN | Healthcare | 1.4% | $133.5m | 4,520,000 | 0% | held |
| 20 | TNGX TANGO THERAPEUTICS INC | Healthcare | 1.4% | $131.0m | 4,190,611 | 1% | added |
| 21 | AHCO ADAPTHEALTH CORP | Healthcare | 1.2% | $119.6m | 11,477,730 | 0% | held |
| 22 | PHVS PHARVARIS N V | Healthcare | 1.2% | $116.7m | 3,376,042 | 8% | added |
| 23 | CELCUITY INC | 1.2% | $113.8m | 100,000,000 | – | new | |
| 24 | ARWR ARROWHEAD PHARMACEUTICALS IN | Healthcare | 1.2% | $113.2m | 1,389,055 | -12% | reduced |
| 25 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 1.1% | $109.7m | 1,125,313 | 10% | added |
| 26 | LRMR LARIMAR THERAPEUTICS INC | Healthcare | 1.1% | $108.6m | 35,606,974 | 0% | held |
| 27 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 1.1% | $106.8m | 3,958,000 | – | new |
| 28 | ALIGNMENT HEALTHCARE INC | 1.1% | $103.8m | 61,000,000 | 0% | held | |
| 29 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 1.1% | $101.2m | 2,714,503 | 77% | added |
| 30 | XENE XENON PHARMACEUTICALS INC | Healthcare | 1.0% | $97.5m | 1,615,696 | 0% | held |
| 31 | IONIS PHARMACEUTICALS INC | 1.0% | $93.1m | 60,000,000 | 0% | held | |
| 32 | SVRA SAVARA INC | Healthcare | 0.9% | $83.6m | 13,569,000 | 0% | held |
| 33 | LNTH LANTHEUS HLDGS INC | Healthcare | 0.9% | $83.5m | 752,999 | -9% | reduced |
| 34 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 0.9% | $82.6m | 3,779,900 | 0% | held |
| 35 | ZENAS BIOPHARMA INC | 0.8% | $80.3m | 67,200,000 | 3% | added | |
| 36 | BMRN BIOMARIN PHARMACEUTICAL INC | Healthcare | 0.8% | $76.3m | 1,332,836 | 57% | added |
| 37 | PFE PFIZER INC | Healthcare | 0.8% | $73.2m | 3,040,000 | 0% | held |
| 38 | INDV INDIVIOR PHARMACEUTICALS INC | Healthcare | 0.7% | $67.7m | 1,648,895 | -47% | reduced |
| 39 | BIO BIO RAD LABS INC | Healthcare | 0.7% | $66.4m | 226,070 | 0% | held |
| 40 | SPRY ARS PHARMACEUTICALS INC | Healthcare | 0.6% | $60.1m | 7,503,812 | 0% | held |
| 41 | STOK STOKE THERAPEUTICS INC | Healthcare | 0.6% | $59.7m | 1,823,500 | 0% | held |
| 42 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 0.6% | $58.3m | 1,086,000 | 41% | added |
| 43 | NVST ENVISTA HOLDINGS CORPORATION | Healthcare | 0.6% | $58.2m | 2,210,100 | 0% | held |
| 44 | INSP INSPIRE MED SYS INC | Healthcare | 0.6% | $57.9m | 1,296,862 | -52% | reduced |
| 45 | CDNA CAREDX INC | Healthcare | 0.6% | $56.9m | 1,997,618 | -9% | reduced |
| 46 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 0.6% | $56.1m | 1,315,000 | – | new |
| 47 | BLTE BELITE BIO INC | Healthcare | 0.6% | $55.0m | 357,199 | 17% | added |
| 48 | PARABILIS MEDICINES INC | 0.5% | $51.5m | 1,880,704 | – | new | |
| 49 | CERT CERTARA INC | Healthcare | 0.5% | $49.2m | 7,512,928 | -4% | reduced |
| 50 | IRON DISC MEDICINE INC | Healthcare | 0.5% | $48.1m | 657,000 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.